These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 8596599)
21. Requirements for extinction of relapse-facilitating variables and for rehabilitation in a narcotic-antagonist treatment program. Wikler A Adv Biochem Psychopharmacol; 1973; 8(0):399-414. PubMed ID: 4795072 [No Abstract] [Full Text] [Related]
22. Cocaine abuse: a review of current and experimental treatments. Kleber HD; Gawin FH NIDA Res Monogr; 1984; 50():111-29. PubMed ID: 6440022 [No Abstract] [Full Text] [Related]
23. Management of cocaine abuse in methadone maintenance programs. Kolar AF Md Med J; 1989 Dec; 38(12):1067-8. PubMed ID: 2615578 [No Abstract] [Full Text] [Related]
24. Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans. Walsh SL; Sullivan JT; Preston KL; Garner JE; Bigelow GE J Pharmacol Exp Ther; 1996 Nov; 279(2):524-38. PubMed ID: 8930154 [TBL] [Abstract][Full Text] [Related]
25. 28. Methadone maintenance and its implication for theories of narcotic addiction. Dole VP; Nyswander ME Res Publ Assoc Res Nerv Ment Dis; 1968; 46():359-66. PubMed ID: 5723803 [No Abstract] [Full Text] [Related]
26. Antagonists to the battle. DiPalma JR RN; 1976 Nov; 39(11):95-6, 98. PubMed ID: 1049452 [No Abstract] [Full Text] [Related]
27. Cognitive-neuromotor assessment of substance abuse: focus on issues related to cocaine abuse treatment. Ellinwood EH; Lee TH NIDA Res Monogr; 1997; 175():192-207. PubMed ID: 9467799 [No Abstract] [Full Text] [Related]
34. The spectrum of cocaine abuse and its treatment. Kleber HD; Gawin FH J Clin Psychiatry; 1984 Dec; 45(12 Pt 2):18-23. PubMed ID: 6438067 [TBL] [Abstract][Full Text] [Related]
35. International Narcotics Research Conference (INRC) 2006. Chavkin C IDrugs; 2006 Oct; 9(10):693-5. PubMed ID: 17016774 [No Abstract] [Full Text] [Related]
36. Goals and rationale for pharmacotherapeutic approach in treating cocaine dependence: insights from basic and clinical research. Kreek MJ NIDA Res Monogr; 1997; 175():5-35. PubMed ID: 9467791 [No Abstract] [Full Text] [Related]
37. A history of the development of narcotic antagonists for the treatment of narcotic addiction. Martin WR NIDA Res Monogr; 1978; (19):296-300. PubMed ID: 218106 [No Abstract] [Full Text] [Related]
38. Outcome measurement considerations: pharmacological treatments for substance abuse. Moras K NIDA Res Monogr; 1997; 175():118-36. PubMed ID: 9467795 [No Abstract] [Full Text] [Related]
39. Behavioral pharmacology of narcotic antagonists. Mello NK NIDA Res Monogr; 1978; (19):126-41. PubMed ID: 218104 [No Abstract] [Full Text] [Related]
40. Narcotic antagonists: another approach to addiction therapy. Fink M; Freedman AM; Zaks AM; Resnick RB Am J Nurs; 1971 Jul; 71(7):1359-63. PubMed ID: 5207098 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]